CIK 0001668397
- Large accelerated filer
Medpace Holdings, Inc.
Sign in to watch- Ticker
- MEDP
- Exchange
- Nasdaq
- Industry
- Services-Commercial Physical & Biological Research
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 320434904
- Phone
- +1 513-579-9911
- Business address
- 5375 MEDPACE WAY, CINCINNATI, OH, 45227
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $174,850,299
- in 14 filings
Net −$174,850,299. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-02-16 | Medpace Investors, LLC 10% owner | Sale | −50,000 | $391.75 | $19.6M | 5,539,947 |
| 2024-02-16 | Troendle August J. CEO | Sale | −50,000 | $391.75 | $19.6M | 5,539,947 |
| 2024-02-08 | McCarthy Cornelius P. III Director | Exercise or conversion | +4,710 | $57.17 | $269K | 5,038 |
| 2024-02-08 | McCarthy Cornelius P. III Director | Exercise or conversion · Stock Option (Right to Buy) | −4,710 | 0 | ||
| 2023-12-31 | Kraft Robert O. Director | Exercise or conversion | +94 | 376 | ||
| 2023-12-31 | Kraft Robert O. Director | Exercise or conversion · Restricted Stock Unit | −94 | 0 | ||
| 2023-12-31 | McCarthy Cornelius P. III Director | Exercise or conversion | +82 | 328 | ||
| 2023-12-31 | McCarthy Cornelius P. III Director | Exercise or conversion · Restricted Stock Unit | −82 | 0 | ||
| 2023-12-31 | Carley Brian T Director | Exercise or conversion | +103 | 7,813 | ||
| 2023-12-31 | Carley Brian T Director | Exercise or conversion · Restricted Stock Unit | −103 | 0 | ||
| 2023-12-15 | BURWIG SUSAN E Exec. VP, Operations | Sale | −2,009 | $303.00 | $609K | 15,283 |
| 2023-12-14 | BURWIG SUSAN E Exec. VP, Operations | Sale | −10,391 | $304.15 | $3.2M | 17,292 |
| 2023-12-01 | Troendle August J. CEO | Sale | −24,039 | $273.26 | $6.6M | 5,589,947 |
| 2023-12-01 | Medpace Investors, LLC 10% owner | Sale | −24,039 | $273.26 | $6.6M | 5,589,947 |
| 2023-11-30 | McCarthy Cornelius P. III Director | Grant or award · Restricted Stock Unit | +249 | $270.72 | $67K | 249 |
| 2023-11-30 | Kraft Robert O. Director | Grant or award · Restricted Stock Unit | +286 | $270.72 | $77K | 286 |
| 2023-11-30 | Carley Brian T Director | Grant or award · Restricted Stock Unit | +313 | $270.72 | $85K | 313 |
| 2023-11-30 | Troendle August J. CEO | Sale | −7,871 | $272.18 | $2.1M | 5,613,986 |
| 2023-11-30 | Medpace Investors, LLC 10% owner | Sale | −7,871 | $272.18 | $2.1M | 5,613,986 |
| 2023-11-29 | Troendle August J. CEO | Sale | −3,167 | $272.87 | $864K | 5,639,947 |
Page 18 of 20 · 391 trades